Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Semaglutide 1mg/0.74ml inj 3ml pre-filled disposable devices
0601023AWAAACAC
|
Semaglutide | Semaglutide | Endocrine System | 30,170 |
|
Sodium valproate 500mg modified-release tablets
0408010W0AAA2A2
|
Sodium valproate | Sodium valproate | Central Nervous System | 30,132 |
|
Cosopt 20mg/ml / 5mg/ml eye dps 0.2ml ud preservative free
1106000ABBBABAB
|
Cosopt | Dorzolamide and timolol | Eye | 30,093 |
|
Methocarbamol 750mg tablets
1002020S0AAABAB
|
Methocarbamol | Methocarbamol | Musculoskeletal and Joint Diseases | 30,072 |
|
Loratadine 5mg/5ml oral solution
0304010D0AAABAB
|
Loratadine | Loratadine | Respiratory System | 30,051 |
|
Alginate raft-forming oral suspension sugar free
0101021B0AAAHAH
|
Alginic acid compound preparation | Alginic acid compound preparations | Gastro-Intestinal System | 30,043 |
|
Dressit sterile dressing pack with gloves
20030100167
|
Dressit sterile dressing pack with gloves | Wound Management & Other Dressings | Dressings | 29,999 |
|
Sevodyne 10micrograms/hour transdermal patches
0407020B0BMABAI
|
Sevodyne | Buprenorphine | Central Nervous System | 29,952 |
|
Madopar 50mg/12.5mg capsules
0409010K0BBAIAI
|
Madopar | Co-beneldopa (Benserazide/levodopa) | Central Nervous System | 29,894 |
|
Buspirone 5mg tablets
0401020B0AAAAAA
|
Buspirone hydrochloride | Buspirone hydrochloride | Central Nervous System | 29,868 |
|
Yaltormin SR 500mg tablets
0601022B0BPAAAS
|
Yaltormin | Metformin hydrochloride | Endocrine System | 29,867 |
|
Sereflo 25micrograms/dose / 125micrograms/dose inhaler
0302000N0BIAABF
|
Sereflo | Fluticasone propionate (Inhalation) | Respiratory System | 29,844 |
|
Shortec 5mg capsules
0407020ADBJAAAC
|
Shortec | Oxycodone hydrochloride | Central Nervous System | 29,740 |
|
Travoprost 40micrograms/ml / Timolol 5mg/ml eye drops
1106000AHAAAAAA
|
Timolol/travoprost | Timolol and travoprost | Eye | 29,690 |
|
NACSYS 600mg effervescent tablets
0307000C0BNAAAR
|
NACSYS | Acetylcysteine | Respiratory System | 29,659 |
|
Betamethasone dipropionate 0.064% / Clotrimazole 1% cream
1304000D0AACACA
|
Betamethasone esters | Betamethasone esters | Skin | 29,639 |
|
GlucoRx FinePoint Ultra hypod ins needles for pre-filled/reusable pen injectors screw on 4mm/32gauge
21010900697
|
GlucoRx FinePoint Ultra hypod ins needles for pre-filled/reusable pen injectors screw on 4mm/32gauge | Other Appliances | Appliances | 29,574 |
|
Carbocisteine 250mg/5ml oral solution
0307000J0AAACAC
|
Carbocisteine | Carbocisteine | Respiratory System | 29,560 |
|
Rivaroxaban 2.5mg tablets
0208020Y0AAADAD
|
Rivaroxaban | Rivaroxaban | Cardiovascular System | 29,560 |
|
Fesoterodine 4mg modified-release tablets
0704020ADAAAAAA
|
Fesoterodine fumarate | Fesoterodine fumarate | Obstetrics, Gynaecology and Urinary-Tract Disorders | 29,553 |
|
Sitagliptin 50mg / Metformin 1g tablets
0601023ADAAAAAA
|
Metformin hydrochloride/sitagliptin | Metformin hydrochloride/sitagliptin | Endocrine System | 29,549 |
|
Cyanocobalamin 1mg tablets
0901020D0AAAFAF
|
Cyanocobalamin | Cyanocobalamin | Nutrition and Blood | 29,525 |
|
Duac Once Daily gel (5% and 1%)
1306010Y0BBAAAA
|
Duac | Benzoyl peroxide and clindamycin phosphate | Skin | 29,514 |
|
Fortisip Compact liquid (8 flavours)
0913011V0BDAAAD
|
Fortisip ready to serve 2.4 kcal/ml milkshake lower volume | Ready to serve 2.4 kcal/ml milkshake lower volume (0913011) | Nutrition and Blood | 29,503 |
|
Carmellose 0.5% eye drops 0.4ml unit dose preservative free
1108010D0AAADAD
|
Carmellose sodium (Eye) | Carmellose sodium | Eye | 29,478 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.